2,201
Views
5
CrossRef citations to date
0
Altmetric
Review

Aidi injection as adjunctive treatment to gemcitabine-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis

, , , , , & show all
Pages 1258-1273 | Received 22 Feb 2021, Accepted 21 Aug 2021, Published online: 19 Sep 2021

References

  • Baggstrom MQ, Stinchcombe TE, Fried DB, Poole C, Hensing TA, Socinski MA. 2007. Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis. J Thorac Oncol. 2(9):845–853.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
  • Chen R, Wang W. 2014. Effect analysis of Aidi injection combined with GP regimen in treatment of advanced non-small cell lung cancer. Chin Modern Med. 21:84–85,91.
  • Chen Y. 2016. Effect of Aidi injection combined with chemotherapy on serum VEGF-C and CYFR21-1 levels in patients with advanced non-small cell lung cancer. Chin J Clin Ration Drug Use. 9:5–6.
  • Cichello SA, Yao Q, Dowell A, Leury B, He XQ. 2015. Proliferative and inhibitory activity of Siberian ginseng (Eleutherococcus senticosus) extract on cancer cell lines; A-549, XWLC-05, HCT-116, CNE and Beas-2b. Asian Pac J Cancer Prev. 16(11):4781–4786.
  • Dai PC, Liu DL, Zhang L, Ye J, Wang Q, Zhang HW, Lin XH, Lai GX. 2017. Astragaloside IV sensitizes non-small cell lung cancer cells to gefitinib potentially via regulation of SIRT6. Tumour Biol. 39(4):1010428317697555.
  • de Castro J, Tagliaferri P, de Lima VCC, Ng S, Thomas M, Arunachalam A, Cao X, Kothari S, Burke T, Myeong H, et al. 2017. Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study. Eur J Cancer Care. 26:e12734.
  • Ding P, Ge H, Li M, Zhu M. 2011. Clinical study of Aidi combined with GP regimen in the treatment of advanced non-small cell lung cancer. J Clinic Pulm Med. 16:1802–1803.
  • Efferth T, Li PC, Konkimalla VS, Kaina B. 2007. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med. 13(8):353–361.
  • Fan S, Peng L, Qi X. 2011. Clinical observation of Aidi injection combined with chemotherapy for advanced non-small cell lung cancer. Zhejiang J Integr Tradit West Med. 21:232–233.
  • Fang L. 2016. Aidi injection combined with GP regimen for curative effect observation III∼IV stage non-small cell lung cancer. J Med Forum. 37:74–75.
  • Fu L. 2012. Clinical effect analysis of Aidi injection combined with GP chemotherapy in elderly patients with advanced non-small cell lung cancer. Guide Chin Med. 10:466.
  • Ge G, Yan Y, Cai H. 2017. Ginsenoside Rh2 inhibited proliferation by inducing ROS mediated ER stress dependent apoptosis in lung cancer cells. Biol Pharm Bull. 40(12):2117–2124.
  • Geng K, Dong J, Su H, Dai C, Chen J, Yue X. 2020. Efficacy and safety of Aidi injection combined with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer. Henan Med Res. 29:2231–2232.
  • Guo X. 2020. Effect analysis of Aidi injection combined with GP regimen in treatment of advanced NSCLC. Pract Clin J Integr Tradit West Med. 20:104–105.
  • Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. 2008. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 336(7650):924–926.
  • Han R, Wang A, Yang G, Yang Y, Liu B, Cao X, Li N, Zhou Q, Yan Y. 2015. Effect of Aidi injection on chemotherapy efficacy and immune function of advanced non-small cell lung cancer. Chin J Geron. 35:4878–4879.
  • He W, Wu L, Yu C, Song Y. 2011. Clinical observation of GP regimen combined with Aidi in the treatment of advanced non-small cell lung cancer. Acta Academiae Med CPAF. 20:296–297.
  • Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, Welch V. 2020. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). [accessed 2020 Nov 30]. www.training.cochrane.org/handbook
  • Hong Y, Wang J, Jiao Z. 2010. Clinical observation of Aidi injection combined with GP regimen in treatment of advanced non-small cell lung cancer. Chin J Clin Oncol Rehabil. 17:247–249.
  • Hsia TC, Yu CC, Hsiao YT, Wu SH, Bau DT, Lu HF, Huang YP, Lin JG, Chang SJ, Chung JG. 2016. Cantharidin impairs cell migration and invasion of human lung cancer NCI-H460 cells via UPA and MAPK signaling pathways. Anticancer Res. 36(11):5989–5997.
  • Huang L, Zhao H, Huang B, Zheng C, Peng W, Qin L. 2011. Acanthopanax senticosus: review of botany, chemistry and pharmacology. Pharmazie. 66(2):83–97.
  • Huang W, Zheng J, Guo B. 2017. The clinical effects and influence on the immune function of Aidi injection combined with GP regimen in the treatment of patients with non-small cell lung cancer. J Med Theor Pract. 30:995–997.
  • Jiang S, Mao X, Hong J. 2011. Clinical research on 60 cases of non-small cell lung cancer treated by Aidi injection combined with chemotherapy. Zhejiang J Integr Tradit West Med. 21:24–26.
  • Jiang Z, Yang Y, Yang Y, Zhang Y, Yue Z, Pan Z, Ren X. 2017. Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune. Biomed Pharmacother. 96:378–383.
  • Ju S, Li C, Xu Y. 2013. Clinical efficacy of Aidi injection combined with GP chemotherapy in the treatment of advanced non-small cell lung cancer in the elderly. Strait Pharm. 25:206–207.
  • Lai L. 2013. Efficacy of GP chemotherapy combined with Aidi injection in the treatment of advanced senile non-small cell lung cancer. Modern J Integr Tradit West Med. 22:257–258.
  • Lang K, Marciniak MD, Faries D, Stokes M, Buesching D, Earle C, Treat J, Babineaux S, Morissette N, Thompson D. 2009. Costs of first-line doublet chemotherapy and lifetime medical care in advanced non-small-cell lung cancer in the United States. Value Health. 12(4):481–488.
  • Li H, Dong L, Li Y, Fu S. 2008. Aidi injection combined with GO regimen in the treatment of advanced non-small cell lung cancer. Zhejiang J Integr Tradit West Med. 18:473–475.
  • Li J. 2016. Efficacy of Aidi injection in the treatment of advanced non-small cell lung cancer. Clin J Chin Med. 8:82–84.
  • Li J, Yang G. 2014. Clinical efficacy of Aidi injection combined with GP regimen in advanced non-small cell lung cancer. Heilongjiang Med J. 38:447–448.
  • Li J, Yang Z, Song X, Jian Q, Sun X, Zhang H, LIu W. 2016. Short-term efficacy and safety of Aidi injection adjuvant GP regimen for advanced non-small cell lung cancer. Hebei Med. 38:1345–1347.
  • Li M, Huang H, Tan J, Lin D. 2006. A randomized clinical trial on taxol plus oxaliplatin versus taxol plus cisplatin as first-line treatment in advanced non-small cell lung cancer. Chinese J Lung Cancer. 9:452–454.
  • Li Z, Liu X, Yuan L. 2010. Observation on the efficacy of eti combined with gemcitabine plus cisplatin in the treatment of advanced non-small cell lung cancer. J Community Med. 8:23–24.
  • Lin S, An X, Guo Y, Gu J, Xie T, Wu Q, Sui X. 2019. Meta-analysis of Astragalus-containing traditional Chinese medicine combined with chemotherapy for colorectal cancer: efficacy and safety to tumor response. Front Oncol. 9:749.
  • Liu H, Nie Q, Lu Y, Liu X. 2019. Clinical efficacy of Aidi injection combined with GP regimen in advanced non-small cell lung cancer and its effect on serum VEGF expression and immune function. Jiangxi J Tradit Chin Med. 50:42–44.
  • Liu L, Liu Y, Zhang T. 2010. Short-term efficacy of Aidi injection combined with chemotherapy for advanced non-small cell lung cancer. Natl Med Fron Chin. 5:46–46.
  • Liu Z, Zhang C. 2014. Aidi injection combined with GP regimen in the treatment of advanced non-small cell lung cancer: a randomized parallel control study. J Pract Trad Chin Internal Med. 28:65–67.
  • Lu C, Wang H, Wang J. 2006. Clinical observation of Aidi injection combined with chemotherapy for advanced non-small cell lung cancer. Health Horizon. 14:30–31.
  • Lv D, Guo Q, Qiu Y. 2009. Clinical research on 30 cases of advanced non-small cell lung cancer treated by Aidi injection combined with chemotherapy. Jiangxi J Tradit Chin Med. 40:47–48.
  • Lv L. 2009. Clinical research on 29 cases of advanced non-small cell lung cancer treated by Aidi combined with gemcitabine plus carboplatin regimen. J Shanxi Coll Tradit Chin Med. 10:66–67.
  • Lv W, Hu S, Xiong G, Xiong H. 2018. The clinical effects and influence on the immune function of chemotherapy combined with Traditional Chinese and Western medicine on non-small cell lung cancer patients. Anti-Infection Pharmacy. 15:544–547.
  • Ma J, Zhan Y, Huang C. 2010. Efficacy of Aidi injection combined with chemotherapy in the treatment of non-small cell lung cancer. Guangxi Med J. 32:932–933.
  • Ma Y, Jiang X. 2016. Effect of Aidi injection combined with GP regimen on patients with non-small cell lung cancer. Pract J Cardiac Cereb Pneum Vasc Dis. 24:89–92.
  • Ma M. 2017. Effect of Aidi injection combined with GP chemotherapy on patients with advanced NSCLC with QI-Yin deficiency and its influence on immune function and coagulation function. Asia-Pacific Tradit Med. 13:108–110.
  • Ma WH, Duan KN, Feng M, She B, Chen Y, Zhang RM. 2009. Aidi Injection as an adjunct therapy for non-small cell lung cancer: a systematic review. Zhong Xi Yi Jie He Xue Bao. 7(4):315–324.
  • Majeed F, Malik FZ, Ahmed Z, Afreen A, Afzal MN, Khalid N. 2018. Ginseng phytochemicals as therapeutics in oncology: recent perspectives. Biomed Pharmacother. 100:52–63.
  • Meng Q, Pan J, Liu Y, Chen L, Ren Y. 2017. Anti-tumour effects of polysaccharide extracted from Acanthopanax senticosus and cell-mediated immunity. Exp Ther Med. 15:1694–1701.
  • Miller AB, Hoogstraten B, Staquet M, Winkler A. 1981. Reporting results of cancer treatment. Cancer. 47(1):207–214.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 339:b2535.
  • Morgensztern D, Ng SH, Gao F, Govindan R. 2010. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J Thorac Oncol. 5(1):29–33.
  • Mountain CF. 1989. Value of the new TNM staging system for lung cancer. Chest. 96 (1 Suppl):47s–49s.
  • Ning S, Zhan B, Xu H. 2015. Aidi injection combined with GP regimen in the treatment of advanced non-small cell lung cancer with EGFR-TKI acquired resistance. Drugs Clin. 30:691–695.
  • Pan C, Chu D, Hu Z, Guo S, Du Y. 2012. Efficacy of GP regimen combined with Aidi injection in the treatment of advanced non-small cell lung cancer. Chin J Clin Med. 19:613–615.
  • Pei W. 2012. Effect of Aidi injection combined with GP regimen on serum VEGF in patients with advanced non-small cell lung cancer. Chin Med Her. 09:99–100.
  • Shi W, Cai D, Zhang Y. 2001. Research progress in the role and application of tumor angiogenesis inhibitors. Foreign Med. 28:36–39.
  • Shi X, Yu A, Yang Y, Jin X, Dai L, Zhang T, Wang M, Wang Z, Pan W. 2010. Clinical observation of Aidi injection combined with chemotherapy for advanced non-small cell lung cancer. Zhejiang J Integr Tradit West Med. 20:747–748.
  • Siegel RL, Miller KD, Jemal A. 2020. Cancer statistics, 2020. CA A Cancer J Clin. 70(1):7–30.
  • Song Z, Liu X, Zhang H, Shang D, Xu Y. 2009. Efficacy of Aidi injection combined with GP regimen in the treatment of advanced non-small cell lung cancer. Med Res Educ. 26:36–37.
  • Su D, Zhang X. 2019. Clinical observation of Aidi injection combined with GP chemotherapy in the treatment of non-small cell lung cancer. J Basic Clin Oncol. 32:31–34.
  • Sun J, Xu P, Shi D, Cao B. 2012. Clinical efficacy evaluation of Aidi injection combined with GP chemotherapy in the treatment of advanced non-small cell lung cancer in the elderly. J Jilin Univ. 38:151–154.
  • Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, et al. 2003. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 13(3):176–181.
  • Wang J. 2012. Efficacy of Aidi injection combined with GP regimen in the treatment of non-small cell lung cancer. J Clin Pulm Med. 17:312–313.
  • Wang Y, Peng L. 2012. Clinical study of Aidi combined with GP regimen in the treatment of advanced non-small cell lung cancer. Chin Community Doct. 14:231.
  • Wang J, Li G, Yu L, Mo T, Wu Q, Zhou Z. 2018a. Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: a meta-analysis of 42 RCTs following the PRISMA guidelines. J Ethnopharmacol. 221:137–150.
  • Wang J, Tian L, Khan MN, Zhang L, Chen Q, Zhao Y, Yan Q, Fu L, Liu J. 2018b. Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and stemness. Cancer Lett. 415:73–85.
  • Watanabe H, Yamamoto S, Kunitoh H, Sekine I, Yamamoto N, Ohe Y, Tamura T, Kodama T, Sugimura K, Saijo N. 2003. Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Sci. 94(11):1015–1020.
  • Wen H. 2014. Clinical observation of combined Traditional Chinese and Western medicine in the treatment of advanced non-small cell lung cancer in the elderly. Modern J Integr Tradit West Med. 23:2325–2326.
  • Wen K, Li J, Peng D. 2009. Efficacy of Aidi injection combined with GP regimen in the treatment of advanced non-small cell lung cancer. Chin J Basic Med Tradit Chin Med. 15:716–717.
  • Wu T, Chen S. 2017. Feasibility study of Aidi injection combined with chemotherapy in non-small cell lung cancer. Chin Foreign Med Treat. 36:126–127,136.
  • Wu X, Wu Q, Zhou X, Huang J. 2019. SphK1 functions downstream of IGF-1 to modulate IGF-1-induced EMT, migration and paclitaxel resistance of A549 cells: a preliminary in vitro study. J Cancer. 10(18):4264–4269.
  • Wu Y, Qu Z, Tao H. 2017. Efficacy of Aidi injection combined with chemotherapy in the treatment of advanced non-small cell lung cancer. Shanxi J Tradit Chin. 38:883–884.
  • Xiang Y, Guo Z, Zhu P, Chen J, Huang Y. 2019. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science. Cancer Med. 8(5):1958–1975.
  • Xiao Y. 2006. Clinical observation of Aidi injection combined with chemotherapy in the treatment of advanced non-small cell lung cancer in the elderly. J Clin Pulm Med. 11:286–287.
  • Xiao Z, Wang C, Sun Y, Li N, Li J, Chen L, Yao X, Ding J, Ma H. 2016. Can Aidi injection restore cellular immunity and improve clinical efficacy in non-small-cell lung cancer patients treated with platinum-based chemotherapy? A meta-analysis of 17 randomized controlled trials following the PRISMA guidelines. Medicine. 95(44):e5210.
  • Yang Q, Chen W, Huang J, Chen X. 2008. Aidi injection combined with chemotherapy in the treatment of advanced lung cancer. Guangming J Chin Med. 23:1760–1761.
  • Yates JW, Chalmer B, McKegney FP. 1980. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 45(8):2220–2224.
  • Yoon TJ, Yoo YC, Lee SW, Shin KS, Choi WH, Hwang SH, Ha ES, Jo SK, Kim SH, Park WM. 2004. Anti-metastatic activity of Acanthopanax senticosus extract and its possible immunological mechanism of action. J Ethnopharmacol. 93(2–3):247–253.
  • Zhang A, Zheng Y, Que Z, Zhang L, Lin S, Le V, Liu J, Tian J. 2014. Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO. J Cancer Res Clin Oncol. 140(11):1883–1890.
  • Zhang H. 2014. Effect of Aidi injection combined with GP chemotherapy regimen on serum VEGF and immune function in patients with non-small cell lung cancer. Chin J Modern Med. 24:40–43.
  • Zhang H. 2018. Effect of Aidi injection on toxic and side effects in patients with advanced NSCLC undergoing chemotherapy. Jilin Med J. 39:134–136.
  • Zhang H, Cai S, Chen J, Chen F. 2018. Feasibility study of Aidi injection combined with chemotherapy in the treatment of non-small cell lung cancer. Chin Conti Med Educ. 9:195–196.
  • Zhang L. 2009. Clinical observation of Aidi combined with GP regimen in the treatment of advanced non-small cell lung cancer. J Pract Med. 25:2929–2930.
  • Zhang S. 2016. Short-term and long-term efficacy of Aidi injection in the treatment of advanced lung cancer. J Today Health. 15:46.
  • Zhang X. 2016. Clinical observation of Aidi injection combined with GP regimen in the treatment of non-small cell lung cancer. J Liaoning Univ Tradit Chin Med. 18:173–175.
  • Zhang Y. 2012. Efficacy of Aidi injection combined with GP regimen in the treatment of non-small cell lung cancer. Modern J Integr Tradit West Med. 21:2095–2096.
  • Zhang Y, Wang H. 2008. Clinical observation of GCb combined with Aidi in the treatment of advanced non-small cell lung cancer. J Liaoning Univ Tradit Chin Med. 10:73–74.
  • Zhao J, Li J. 2019. Effect of Aidi injection combined with GP regimen in advanced non-small cell lung cancer. Clin Res Pract. 4:117–119.
  • Zou Y, Li J, Luo X. 2006. Clinical observation of Aidi injection combined with GP chemotherapy in the treatment of advanced lung cancer. Hubei J Tradit Chin Med. 28:33–34.